- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
VRIO Analysis of Oral Insulin Breakthrough Innovation at Biocon
Posted by Zachary Edwards on Mar-22-2018
The VRIO Analysis of Oral Insulin Breakthrough Innovation at Biocon will look at each of its internal resources one by one to assess whether these provide sustained competitive advantage. The Oral Insulin Breakthrough Innovation at Biocon VRIO Analysis also mentions at each stage whether these resources could be improved to provide a greater competitive advantage. Lastly, the resources analysed are summarised as to whether they offer sustained competitive advantage, has an unused competitive advantage, temporary competitive advantage, competitive parity or competitive disadvantage.
Valuable
- The Oral Insulin Breakthrough Innovation at Biocon VRIO Analysis shows that the financial resources of Oral Insulin Breakthrough Innovation at Biocon are highly valuable as these help in investing into external opportunities that arise. These also help Oral Insulin Breakthrough Innovation at Biocon in combating external threats.
- According to the VRIO Analysis of Oral Insulin Breakthrough Innovation at Biocon, its local food products are a valuable resource as these are highly differentiated. This makes the perceived value for these by customers high. These are also valued more than the competition by customers due to the differentiation in these products.
- The Oral Insulin Breakthrough Innovation at Biocon VRIO Analysis shows that Oral Insulin Breakthrough Innovation at Biocon's employees are a valuable resource to the firm. A significant portion of the workforce is highly trained, and this leads to more productive output for the organisation. The employees are also loyal, and retention levels for the organisation are high. All of this translates into greater value for the end consumers of Oral Insulin Breakthrough Innovation at Biocon's products.
- According to the VRIO Analysis of Oral Insulin Breakthrough Innovation at Biocon, its patents are a valuable resource as these allow the firm to sell its products without competitive interference. This results in greater revenue for Oral Insulin Breakthrough Innovation at Biocon. These patents also provide Oral Insulin Breakthrough Innovation at Biocon with licensing revenue when it licenses these patents out to other manufacturers.
- The Oral Insulin Breakthrough Innovation at Biocon VRIO Analysis shows that Oral Insulin Breakthrough Innovation at Biocon’s distribution network is a valuable resource. This helps it in reaching out to more and more customers. This ensures greater revenues for Oral Insulin Breakthrough Innovation at Biocon. It also ensures that promotion activities translate into sales as the products are easily available.
- According to the VRIO Analysis of Oral Insulin Breakthrough Innovation at Biocon, its cost structure is not a valuable resource. This is because the methods of production lead to greater costs than that of competition, which affects the overall profits of the firm. Therefore, its cost structure is a competitive disadvantage that needs to be worked on.
- The Oral Insulin Breakthrough Innovation at Biocon VRIO Analysis shows that the research and development at Oral Insulin Breakthrough Innovation at Biocon is not a valuable resource. This is because research and development are costing more than the benefits it provides in the form of innovation. There have been very few innovative features and breakthrough products in the past few years. Therefore, research and development are a competitive disadvantage for Oral Insulin Breakthrough Innovation at Biocon. It is recommended that the research and development teams are improved, and costs are cut for these.
Rare
- The financial resources of Oral Insulin Breakthrough Innovation at Biocon are found to be rare according to the VRIO Analysis of Oral Insulin Breakthrough Innovation at Biocon. Strong financial resources are only possessed by a few companies in the industry.
- The local food products are found to be not rare as identified by Oral Insulin Breakthrough Innovation at Biocon VRIO Analysis. These are easily provided in the market by other competitors. This means that competitors can use these resources in the same way as Oral Insulin Breakthrough Innovation at Biocon and inhibit competitive advantage. This means that the local food products result in competitive parity for Oral Insulin Breakthrough Innovation at Biocon. As this resource is valuable, Oral Insulin Breakthrough Innovation at Biocon can still make use of this resource.
- The employees of Oral Insulin Breakthrough Innovation at Biocon are a rare resource as identified by the VRIO Analysis of Oral Insulin Breakthrough Innovation at Biocon. These employees are highly trained and skilled, which is not the case with employees in other firms. The better compensation and work environment ensure that these employees do not leave for other firms.
- The patents of Oral Insulin Breakthrough Innovation at Biocon are a rare resource as identified by the Oral Insulin Breakthrough Innovation at Biocon VRIO Analysis. These patents are not easily available and are not possessed by competitors. This allows Oral Insulin Breakthrough Innovation at Biocon to use them without interference from the competition.
- The distribution network of Oral Insulin Breakthrough Innovation at Biocon is a rare resource as identified by the VRIO Analysis of Oral Insulin Breakthrough Innovation at Biocon. This is because competitors would require a lot of investment and time to come up with a better distribution network than that of Oral Insulin Breakthrough Innovation at Biocon. These are also possessed by very few firms in the industry.
Imitable
- The financial resources of Oral Insulin Breakthrough Innovation at Biocon are costly to imitate as identified by the Oral Insulin Breakthrough Innovation at Biocon VRIO Analysis. These resources have been acquired by the company through prolonged profits over the years. New entrants and competitors would require similar profits for a long period of time to accumulate these amounts of financial resources.
- The local food products are not that costly to imitate as identified by the VRIO Analysis of Oral Insulin Breakthrough Innovation at Biocon. These can be acquired by competitors as well if they invest a significant amount in research and development. These also do not require years long experience. Therefore, the local food products by Oral Insulin Breakthrough Innovation at Biocon provide it with a temporary competitive advantage that competitors can too acquire in the long run.
- The employees of Oral Insulin Breakthrough Innovation at Biocon are also not costly to imitate as identified by the Oral Insulin Breakthrough Innovation at Biocon VRIO Analysis. This is because other firms can also train their employees to improve their skills. These companies can also hire employees from Oral Insulin Breakthrough Innovation at Biocon by offering better compensation packages, work environment, benefits, growth opportunities etc. This makes the employees of Oral Insulin Breakthrough Innovation at Biocon a resource that provides a temporary competitive advantage. Competition can acquire these in the future.
- The patents of Oral Insulin Breakthrough Innovation at Biocon are very difficult to imitate as identified by the VRIO Analysis of Oral Insulin Breakthrough Innovation at Biocon. This is because it is not legally allowed to imitate a patented product. Similar resources to be developed and getting a patent for them is also a costly process.
- The distribution network of Oral Insulin Breakthrough Innovation at Biocon is also very costly to imitate by competition as identified by the Oral Insulin Breakthrough Innovation at Biocon VRIO Analysis. This has been developed over the years gradually by Oral Insulin Breakthrough Innovation at Biocon. Competitors would have to invest a significant amount if they are to imitate a similar distribution system.
Organisation
- The financial resources of Oral Insulin Breakthrough Innovation at Biocon are organised to capture value as identified by the VRIO Analysis of Oral Insulin Breakthrough Innovation at Biocon. These resources are used strategically to invest in the right places; making use of opportunities and combatting threats. Therefore, these resources prove to be a source of sustained competitive advantage for Oral Insulin Breakthrough Innovation at Biocon.
- The Patents of Oral Insulin Breakthrough Innovation at Biocon are not well organised as identified by the Oral Insulin Breakthrough Innovation at Biocon VRIO Analysis. This means that the organisation is not using these patents to their full potential. An unused competitive advantage exists that can be changed into a sustainable competitive advantage if Oral Insulin Breakthrough Innovation at Biocon starts selling patented products before the patents expire.
- The distribution network of Oral Insulin Breakthrough Innovation at Biocon is organised as identified by the VRIO Analysis of Oral Insulin Breakthrough Innovation at Biocon. Oral Insulin Breakthrough Innovation at Biocon uses this network to reach out to its customers by ensuring that products are available on all of its outlets. Therefore, these resources prove to be a source of sustained competitive advantage for Oral Insulin Breakthrough Innovation at Biocon.
From the VRIO Analysis of Oral Insulin Breakthrough Innovation at Biocon, it was identified that the financial resources and distribution network provide a sustained competitive advantage. The patents are a source of unused competitive advantage. There exists a temporary competitive advantage for employees. There exists a competitive parity for local food products. Lastly, the cost structure of Oral Insulin Breakthrough Innovation at Biocon is a competitive disadvantage. Research and Development is also a competitive disadvantage.
Warning! This article is only an example and cannot be used for research or reference purposes. If you need help with something similar, please submit your details here.
Andreea Moldovan
5.0
I was about to drop from the submission date and accepted that it’s impossible to write the report in six hours. Started to search for a site with disappointed hands. When I talked to the support team of this service and knew the terms and conditions. I became dependent on them and received the work on time. Work was cool and I’m satisfied with the service.
Charlotte Smith
5.0
Would love to appreciate writer # 353428 here who did great work. Excellent custom paper writing service.
Luo Wezhie
5.0
My experience with this company has always been so great. I got above 80% marks. Thank you!
Emiley Mason
5.0
The Term Paper was written quickly and the prices were low really. Thank you for delivering the paper on time!
Next Articles
- After The BRICs: Choosing From Other Emerging Markets Vrio Analysis
- Great Western Hospital: High Risk Pregnancy Care Vrio Analysis
- Gojo Industries: Aiming For Global Sustainability Leadership Vrio Analysis
- The University Of Texas MD Anderson Cancer Center: Interdisciplinary Cancer Care Vrio Analysis
- Calloway Laboratory: Pee For Profit Vrio Analysis
- Watson Children's Shelter Vrio Analysis
- Embrace (B): Opportunity Assessment Vrio Analysis
- Cruzsalud: Health Care For Low Sectors Vrio Analysis
- SARS Outbreak In Toronto Vrio Analysis
- LifeNet International's Transformation Of African Healthcare Via Social Franchising Vrio Analysis
Previous Articles
- Miracle Mind Hypnosis Centre The London Practice Vrio Analysis
- 3M ESPE AG: Managing Intellectual Property In The Dental Impression Materials Market Vrio Analysis
- Ocimum Biosolutions: From Bioinformatics To Integrated Custom Research Outsourcing Vrio Analysis
- U.S. Preventive Services Task Force: Releasing New Guidelines For Breast Cancer Screening (B) Vrio Analysis
- Supplement To "Battle Of The Bulge Private And Public Solutions To Obesity" Vrio Analysis
- Siemens Medical Solutions: Strategic Turnaround Vrio Analysis
- The Children's Hospital Of Philadelphia: Network Strategy Vrio Analysis
- NationWide Primary Healthcare Services: Evolving Business Model Vrio Analysis
- Singapore's Healthcare Industry Vrio Analysis
- Narayana Hrudayalaya Heart Hospital, Video Vrio Analysis
Be a great writer or hire a greater one!
Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire Case48 with BIG enough reputation.
Our Guarantees
Interesting Fact
Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!